Affordable Access

Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL.

Authors
Type
Published Article
Journal
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Publication Date
Volume
17
Issue
1
Pages
79–84
Identifiers
PMID: 16284056
Source
Medline
License
Unknown

Abstract

Weekly paclitaxel plus capecitabine is a safety and active chemotherapy in previously treated metastatic breast cancer.

Statistics

Seen <100 times